Importantly, MMP9 seems to be transcriptionally regulated by EGFR signalling and involved in the regulation of key signalling pathways in glioma, such as PI3K/AKT, STAT3/5, NFkB, ERK, and SHH25–27. Here, MMP9 is linked to central nervous system cancer.